Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
This clinical trial examines the acceptability and effect of a parenting support intervention for families coping with solid tumor that has spread to other places in the body (metastatic) or has come back (recurrent). Parenting support program may help to reduce common parenting concerns, improve communication between parents and children about cancer, and improve the overall psychological wellbeing of parents.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants must (1) be diagnosed with a metastatic or locally recurrent solid malignant tumor and on active treatment; (2) be at least 18 years old; (3) have at least one dependent child between the ages of 4 and 17 and currently living with the parent; (4) be able to provide informed consent and (5) have a spousal caregiver over the age of 18 who co-parents the child(ren) (i.e. share custody) and is willing and able to consent to participate.*
Disqualifiers
Participants and caregivers who do not read and speak English and who do not have access to the internet.
Trial design
Design model
Parallel
Treatments tested in this trial
Best Practice
Other interventionReceive standard of care
Educational Intervention
Other interventionReceive educational materials and attend videoconference sessions
Questionnaire Administration
Other interventionAncillary studies
Treatment groups
120 Participants
are divided into 2 treatment groupsGroup A: Group I (education material, videoconference session)Experimental treatment 2 interventions
Group B: Group II (waitlist control)Active comparator 2 interventions
Trial outcomes
Primary outcomes
1
Examine the feasibility of implementing a parenting support intervention in 50 patients with an incurable cancer and their spousal caregivers.
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov